Crescent Biopharma, Inc.
CBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $133 | $153 | $6 | $11 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $0 | $0 |
| Total Curr. Assets | $135 | $154 | $6 | $11 |
| Property Plant & Equip (Net) | $2 | $2 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $4 | $3 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $138 | $157 | $6 | $11 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $0 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $17 | $15 | $2 | $4 |
| Total Curr. Liab. | $20 | $17 | $3 | $6 |
| LT Debt | $1 | $1 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22 | $18 | $3 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $4 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$79 | -$55 | -$497 | -$494 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $196 | $190 | $500 | $500 |
| Total Equity | $117 | $139 | $3 | $5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $138 | $157 | $6 | $11 |
| Net Debt | -$132 | -$151 | -$6 | -$11 |